Belp, Switzerland

Rafael M Nunez

This inventor holds 1 USPTO granted patent. Top assignee: University of Iowa Research Foundation. Active years: 1998.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rafael M Nunez: Innovator in Immuno-Regulatory Proteins

Introduction

Rafael M Nunez is a distinguished inventor based in Belp, Switzerland. He has made significant contributions to the field of immunology through his innovative research and patents. His work focuses on the development of gene sequences that have the potential to impact the treatment of IgE mediated diseases.

Latest Patents

One of Nunez's notable patents is for DNA sequences for a soluble form of CD23. This invention discloses the isolation and purification of gene sequences that code for a soluble form of the traditionally membrane-bound immuno-regulatory protein, CD23. This protein plays a crucial role in regulating the amount of IgE present in the blood. Upon cloning and amplification, these procedures may be utilized in the treatment of IgE mediated diseases.

Career Highlights

Nunez is affiliated with the University of Iowa Research Foundation, where he continues to advance his research in immunology. His work has garnered attention for its potential applications in medical treatments and therapies.

Collaborations

Throughout his career, Nunez has collaborated with esteemed colleagues, including Richard G Lynch and Junji Yodoi. These partnerships have further enriched his research and contributed to the advancement of knowledge in the field.

Conclusion

Rafael M Nunez is a prominent inventor whose work in immuno-regulatory proteins has the potential to transform the treatment of IgE mediated diseases. His innovative approach and dedication to research continue to make a significant impact in the field of immunology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…